Skip to content
Search

Latest Stories

Asian neurologist's UK study to revolutionise dementia diagnosis

The team will build on recent breakthroughs in potential dementia blood tests and generate the evidence needed for them to be used more widely

Asian neurologist's UK study to revolutionise dementia diagnosis

An Asian-origin neurologist Dr Ashvini Keshavan is part of a research team in the UK that has been awarded a major grant this week for dementia research.

The team will build on recent breakthroughs in potential dementia blood tests and generate the evidence needed for them to be used more widely in the next five years.


Dr Keshavan, Senior Clinical Research and Honorary Consultant Neurologist Fellow at University College London (UCL), is part of the team that will focus on the most promising biomarker for Alzheimer's disease called p-tau217.

A second team made up of researchers from the Universities of Oxford and Cambridge will test various proteins to detect a variety of dementia-causing diseases.

Both teams will recruit participants from sites spread across the UK with the hope of its cost-effective rollout on the National Health Service (NHS) over time.

“Proteins that underpin various dementia-causing diseases, and particularly Alzheimer's disease, which is the commonest cause of dementia worldwide, are now detectable in blood,” said Dr Keshavan.

“The two studies that have been awarded funding by the Blood Biomarker Challenge grant are both seeking to implement blood tests in real world settings in the UK, to see if blood tests will prove useful in confirming the presence or absence of these diseases in people who have early dementia or mild but progressive cognitive problems," she said.

We want to ensure that our research will reflect the UK's ethnic and socioeconomic diversity and are aiming to broaden access to these tests, as the current gold standard tests to confirm the presence of these diseases are currently not accessible to most UK patients because they are either expensive or invasive,” she added.

The Blood Biomarker Challenge is a multi-million-pound award given by Alzheimer's Society, Alzheimer's Research UK, the UK's National Institute for Health and Research and Gates Ventures and includes funds raised by players of People's Postcode Lottery.

The UCL-led study is called ADAPT and will focus on plasma p-tau217 – a blood marker of Alzheimer's disease – and will answer the question of whether knowledge of this test result can improve rates of Alzheimer's diagnosis in conjunction with standard memory clinic assessments.

The second study is called READ-OUT, which aims to test various proteins, including novel or less well-established ones, to detect a variety of dementia-causing diseases.

“If our research shows that these tests are clinically useful, and cost-effective, we would be able to contribute to the case for them becoming a part of the standard of care offered in the UK. This would have the potential for individuals to receive earlier diagnoses of their specific dementia-causing disease,” said Dr Keshavan.

Such a breakthrough would be particularly important for ensuring patients are given the right post-diagnostic support and treatment for symptoms.

“An early, accurate diagnosis of Alzheimer's disease is already important, allowing people to access appropriate care and medications. If, as we hope, new treatments that can slow down Alzheimer's disease become available soon, then this will be vital. This would pave the way for fair and equitable access to new and potentially life-changing treatments to all who might benefit,” added Professor Jonathan Schott, Alzheimer's Research UK Chief Medical Officer and Dr Keshavan's UCL colleague on the research.

Currently, people are usually diagnosed with dementia using memory tests and brain scans. These are less accurate than “gold standard” tests like PET scans or lumbar punctures, which can confirm what type of dementia they have. However, only 2 per cent of people can access these specialist tests.

In recent years, a number of different blood tests that can diagnose Alzheimer's disease and other causes of dementia have shown very promising results in research settings. But they have yet to be tested widely in clinical settings in the UK. (PTI)

More For You

uk-railways-iStock

The package includes £415 million to upgrade the rail line between Manchester, Huddersfield, Leeds, and York, a route affected by delays and disruptions. (Representational image: iStock)

iStock

Government announces £1.7 bn transport investment for the North

THE GOVERNMENT has announced a £1.7 billion investment to improve transport infrastructure across the North, focusing on buses, roads, and rail.

The funding aims to upgrade key routes and improve connectivity across the region.

Keep ReadingShow less
Keir-Starmer-Getty

Keir Starmer’s communications chief has resigned after nine months in Downing Street. (Photo: Getty Images)

Getty Images

Starmer’s communications chief Matthew Doyle resigns after nine months

KEIR STARMER’s communications chief, Matthew Doyle, has resigned after nine months in Downing Street. Doyle, a Labour veteran who previously worked for Tony Blair, joined Starmer’s team as communications director four years ago when the party was in opposition.

His departure follows that of Sue Gray, Starmer’s former chief of staff, who left in the autumn. Doyle’s exit is expected to lead to the promotions of James Lyons to director of communications (strategy) and Steph Driver to director of communications (delivery), according to the BBC.

Keep ReadingShow less
Leicester leaders push for major expansion amid local government shake-up

Leicester’s population is expected to grow from 372,000 now to just over 600,000 by 2028

Leicester leaders push for major expansion amid local government shake-up

Hannah Richardson

LEICESTER leaders have named the areas they want to be incorporated into the city amid a shake-up of local government structures. The massive expansion plan would see a number of towns and villages at the city’s edges brought inside Leicester’s boundary.

Leicester City Council is looking to take part of Blaby and Harborough districts, and part of Oadby and Wigston and Charnwood boroughs. Among the communities being eyed up are Glenfield, Oadby, Wigston, Blaby, Whetstone, Syston, Anstey, Leicester Forest East, Birstall, Kirby Muxloe, Thurmaston and Countesthorpe.

Keep ReadingShow less
Lakshmi-Mittal-Getty

Mittal, who built his steel business over five decades, moved to the UK in 1995. (Photo: Getty Images)

Getty Images

Lakshmi Mittal may leave UK after non-dom tax abolition: report

STEEL tycoon Lakshmi Mittal is considering leaving the UK following the government’s decision to abolish the non-domiciled tax status. The move would make him one of the most prominent entrepreneurs to leave due to the tax reform.

Mittal, who has lived in the UK for three decades, has informed associates that his departure is likely due to Labour’s decision to end the non-dom regime, which allowed certain residents to avoid paying UK tax on foreign income.

Keep ReadingShow less
King Charles

The palace said in a statement that after receiving scheduled treatment in the morning, the king had 'temporary side effects that required a short period of observation in hospital.' (Photo: Getty Images)

Getty Images

King Charles cancels engagements after cancer treatment side effects

KING CHARLES has postponed his engagements for Thursday and Friday after experiencing side effects from his ongoing cancer treatment, Buckingham Palace announced.

The palace said in a statement that after receiving scheduled treatment in the morning, the king had "temporary side effects that required a short period of observation in hospital."

Keep ReadingShow less